Detalhe da pesquisa
1.
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain.
Pharmacoecon Open
; 8(2): 291-302, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236526
2.
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
Thorax
; 68(11): 1007-14, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130227
3.
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
J Health Econ Outcomes Res
; 10(2): 141-149, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145114
4.
Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain.
Drug Discov Ther
; 16(2): 63-71, 2022 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491233